Zosano Pharma Stock Price

0.0071 (1.01%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Zosano Pharma Corporation ZSAN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0071 1.01% 0.71 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.7029 0.690364 0.7189 0.7121 0.7029
Bid Price Ask Price Spread News
0.71 0.7298 0.0198 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,078 640,426 $ 0.7067717 $ 452,635 - 0.3275 - 3.06
Last Trade Time Type Quantity Stock Price Currency
18:46:29 formt 1,000 $ 0.71 USD


Draw Mode:

Zosano Pharma Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 82.07M 115.59M 112.75M $ 224.00k $ - -0.53 -2.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 206.72k 1.60%

more financials information »

Zosano Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZSAN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.69930.730.67660.7077119794,6170.01071.53%
1 Month0.69210.78880.6660.7140863944,8170.01792.59%
3 Months0.920.92990.5960.73996311,084,949-0.21-22.83%
6 Months1.2891.310.5960.87653531,711,930-0.579-44.92%
1 Year1.643.060.32751.094,962,590-0.93-56.71%
3 Years4.006.650.32751.432,741,802-3.29-82.25%
5 Years15.2070.780.32756.772,053,713-14.49-95.33%

Zosano Pharma Description

Zosano Pharma Corp is a clinical-stage biopharmaceutical company. It is focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using the proprietary transdermal microneedle system. The system is designed to facilitate rapid drug absorption into the bloodstream, which can result in an improved pharmacokinetic profile compared to original dosage forms. The company's operating segment is to develop human pharmaceutical products. Its primary product candidate is Qtrypta (M207) which is the proprietary formulation of zolmitriptan delivered utilizing the system.

Your Recent History
Zosano Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.